Antiangiogenic agents
Data up to Jan 2025
Total Citations Per Year
Abstract
References (24)
Tumor Angiogenesis: Therapeutic Implications
1971 • 9,898 citations
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
1997 • 1,705 citations
SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types.
1999 • 1,044 citations
Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.
1998 • 887 citations
The role of αv integrins during angiogenesis: insights into potential mechanisms of action and clinical development
1999 • 651 citations
Endostatin Induces Endothelial Cell Apoptosis
1999 • 594 citations
Angiostatin binds ATP synthase on the surface of human endothelial cells
1999 • 520 citations
Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain
1998 • 477 citations
Structure of Human Methionine Aminopeptidase-2 Complexed with Fumagillin
1998 • 431 citations
Kringle Domains of Human Angiostatin
1996 • 366 citations
Combretastatin A-4 phosphate as a tumor vascular-targeting agent: early effects in tumors and normal tissues.
1999 • 332 citations
Matrix metalloproteinases
1998 • 267 citations
Manipulating Angiogenesis
1997 • 260 citations
Broad Antitumor and Antiangiogenic Activities of AG3340, a Potent and Selective MMP Inhibitor Undergoing Advanced Oncology Clinical Trials
1999 • 234 citations
Preclinical Safety Evaluation of rhuMAbVEGF, an Antiangiogenic Humanized Monoclonal Antibody
1999 • 198 citations
Inhibition of urokinase by 4-substituted benzo[b]thiophene-2-carboxamidines: an important new class of selective synthetic urokinase inhibitor.
1993 • 108 citations
Efficacy and Concentration-Response of Murine Anti-VEGF Monoclonal Antibody in Tumor-Bearing Mice and Extrapolation to Humans
1999 • 80 citations
Molecular mechanisms of tumor metastasis and angiogenesis
1999 • 77 citations
Small Molecule Inhibitors of Tumor-Promoted Angiogenesis, Including Protein Tyrosine Kinase Inhibitors
1999 • 67 citations
Angiostatic activity of synthetic inhibitors of urokinase type plasminogen activator.
1999 • 51 citations
Inhibition of vascular endothelial growth factor induced mitogenesis of human endothelial cells by a chimeric anti-kinase insert domain-containing receptor antibody
1999 • 49 citations
Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation
1999 • 45 citations
A novel animal model for hemangiomas: inhibition of hemangioma development by the angiogenesis inhibitor TNP-470.
1999 • 40 citations
Emerging therapeutic targets in angiogenesis
1998 • 1 citations